These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 8732315)

  • 1. Carbamazepine augmentation therapy in three patients with trazodone-resistant unipolar depression.
    Otani K; Yasui N; Kaneko S; Ohkubo T; Osanai T; Sugawara K
    Int Clin Psychopharmacol; 1996 Mar; 11(1):55-7. PubMed ID: 8732315
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of carbamazepine coadministration on plasma concentrations of trazodone and its active metabolite, m-chlorophenylpiperazine.
    Otani K; Ishida M; Kaneko S; Mihara K; Ohkubo T; Osanai T; Sugawara K
    Ther Drug Monit; 1996 Apr; 18(2):164-7. PubMed ID: 8721280
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trazodone induced galactorrhea: a case report.
    Arslan FC; Uysal EK; Ozkorumak E; Tiryaki A
    Gen Hosp Psychiatry; 2015; 37(4):373.e1-2. PubMed ID: 25920951
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction between trazodone and carbamazepine.
    Romero AS; Delgado RG; Peña MF
    Ann Pharmacother; 1999 Dec; 33(12):1370. PubMed ID: 10630840
    [No Abstract]   [Full Text] [Related]  

  • 5. Possible mild serotonin syndrome related to co-prescription of tandospirone and trazodone.
    Kaneda Y; Ohmori T; Okabe H
    Gen Hosp Psychiatry; 2001; 23(2):98-101. PubMed ID: 11354048
    [No Abstract]   [Full Text] [Related]  

  • 6. Probable interaction between trazodone and carbamazepine.
    Sánchez-Romero A; Mayordomo-Aranda A; García-Delgado R; Durán-Quintana JA
    Pharmacopsychiatry; 2011 Jun; 44(4):158-9. PubMed ID: 21710406
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Possible serotonin syndrome with trazodone addition to fluoxetine.
    George TP; Godleski LS
    Biol Psychiatry; 1996 Mar; 39(5):384-5. PubMed ID: 8704074
    [No Abstract]   [Full Text] [Related]  

  • 8. Priapism associated with trazodone in an adolescent with autism.
    Kem DL; Posey DJ; McDougle CJ
    J Am Acad Child Adolesc Psychiatry; 2002 Jul; 41(7):758. PubMed ID: 12108798
    [No Abstract]   [Full Text] [Related]  

  • 9. [Trazodone and venlafaxine in treatment of depressive disorders].
    Florkowski A; Gruszczyński W; Gałecki P; Zboralski K; Kołodziejska I; Mikołajczyk I
    Pol Merkur Lekarski; 2005 May; 18(107):556-9. PubMed ID: 16161955
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dystonia associated with trazodone and sertraline.
    Lewis CF; DeQuardo JR; Tandon R
    J Clin Psychopharmacol; 1997 Feb; 17(1):64-5. PubMed ID: 9004068
    [No Abstract]   [Full Text] [Related]  

  • 11. Complex partial seizures in a patient receiving trazodone.
    Tasini M
    J Clin Psychiatry; 1986 Jun; 47(6):318-9. PubMed ID: 3711031
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between plasma concentrations of trazodone and its active metabolite, m-chlorophenylpiperazine, and its clinical effect in depressed patients.
    Mihara K; Yasui-Furukori N; Kondo T; Ishida M; Ono S; Ohkubo T; Osanai T; Sugawara K; Otani K; Kaneko S
    Ther Drug Monit; 2002 Aug; 24(4):563-6. PubMed ID: 12142643
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serotonin syndrome.
    Bodner RA; Lynch T; Lewis L; Kahn D
    Neurology; 1995 Feb; 45(2):219-23. PubMed ID: 7854515
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between the CYP2D6 genotype and the steady-state plasma concentrations of trazodone and its active metabolite m-chlorophenylpiperazine.
    Mihara K; Otani K; Suzuki A; Yasui N; Nakano H; Meng X; Ohkubo T; Nagasaki T; Kaneko S; Tsuchida S; Sugawara K; Gonzalez FJ
    Psychopharmacology (Berl); 1997 Sep; 133(1):95-8. PubMed ID: 9335086
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Speech dysfunction due to trazodone--fluoxetine combination in traumatic brain injury.
    Patterson DE; Braverman SE; Belandres PV
    Brain Inj; 1997 Apr; 11(4):287-91. PubMed ID: 9134203
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Serotonin neurotrasmission and treatment options for depression].
    Sivolap YP
    Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(11):174-177. PubMed ID: 29265105
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of treatment with trazodone in combination with pindolol or fluoxetine in major depression.
    Maes M; Vandoolaeghe E; Desnyder R
    J Affect Disord; 1996 Dec; 41(3):201-10. PubMed ID: 8988452
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of trazodone and fluoxetine in the treatment of major depression: therapeutic pharmacokinetic and pharmacodynamic interactions through formation of meta-chlorophenylpiperazine.
    Maes M; Westenberg H; Vandoolaeghe E; Demedts P; Wauters A; Neels H; Meltzer HY
    J Clin Psychopharmacol; 1997 Oct; 17(5):358-64. PubMed ID: 9315986
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Other Antidepressants.
    Schwasinger-Schmidt TE; Macaluso M
    Handb Exp Pharmacol; 2019; 250():325-355. PubMed ID: 30194544
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety of trazodone as a sleep agent for inpatients.
    Jayaram G; Rao P
    Psychosomatics; 2005; 46(4):367-9. PubMed ID: 16000681
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.